MedPath

Azeliragon

Generic Name
Azeliragon
Drug Type
Small Molecule
Chemical Formula
C32H38ClN3O2
CAS Number
603148-36-3
Unique Ingredient Identifier
LPU25F15UQ

Overview

Azeliragon has been used in trials studying the treatment of Alzheimer's Disease.

Background

Azeliragon has been used in trials studying the treatment of Alzheimer's Disease.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath